Table 3.
First recurrence and treatments in the surgery and RFA groups
| Characteristics | Surgery group (n = 82) | RFA group (n = 86) | p value‡ |
|---|---|---|---|
| Site of recurrence, n (%) | |||
| Liver* | 80 (98) | 85 (99) | >0.99 |
| Extrahepatic** | 1 (1) | 1 (1) | >0.99 |
| Bone | 0 | 1 (1) | >0.99 |
| Lymph node | 1 (1) | 1 (1) | >0.99 |
| Others | 1 (1) | 0 | 0.98 |
| Number of recurrences in the liver,# n (%) | |||
| Single | 49 (60%) | 61 (71%) | 0.21 |
| Multiple | 31 (38%) | 24 (28%) | |
| Local recurrence,## n (%) | |||
| Absent | 66 (80) | 61 (71) | 0.07 |
| Present | 12 (15) | 24 (28) | |
| Vascular invasion,† n (%) | |||
| Absent | 77 (94) | 81 (94) | 0.42 |
| Present | 1 (1) | 4 (5) | |
| Treatments for first recurrence, n (%) | |||
| Surgery | 13 (16) | 7 (8) | 0.19 |
| RFA | 48 (59) | 52 (60) | 0.92 |
| TACE | 24 (29) | 30 (35) | 0.54 |
| Others | 2 (2) | 3 (3) | >0.99 |
*
Liver metastasis was missed in 2 patients in the surgery group.
**
Extrahepatic recurrence was missed in 2 patients in the surgery group and in 1 patient in the RFA group.
#
Liver recurrence was missed in 2 patients in the surgery group and in 1 patient in the RFA group.
##
Local recurrence was missed in 4 patients in the surgery group and in 1 patient in the RFA group.
†
Vascular invasion was missed in 4 patients in the surgery group and in 1 patient in the RFA group.
‡
χ2 test for categorical variables and Wilcoxon's rank-sum test for continuous variables.